The Jordan Company, LP Closes Investment in WEP Group Holdings Limited


NEW YORK, November 18, 2021 / PRNewswire / – The Jordan Company, LP (“TJC”) today announced that affiliates of The Resolute Fund V, LP (“Resolute V”) have made an investment in WEP Group Holdings Limited (“WEP Clinical Or the “Company”). Resolute V made the investment in partnership with the co-founders of WEP Clinical Jaswinder khera and Jaswant khera who will continue to be significant owners of the business while leading the company through this next phase of growth.

WEP Clinical is a specialty pharmacy services company that partners with drug developers to help patients and physicians quickly access treatments for rare diseases, cancer, and other serious or life-threatening conditions for which no options are available. viable treatment is not available. The Company is a market leader in the design and delivery of extended access and named patient programs, which provide pre-approval access to promising molecules for patients with critical unmet medical needs. Additionally, WEP Clinical offers real-world data collection, market access services, pharmacovigilance services, patient registry, marketing services, clinical trial and research nursing services. comparators.

WEP Clinical has distributed medicines in over 90 countries and leverages its expertise in the physical, legal and regulatory aspects of accessing, distributing and marketing global pharmaceuticals through its suite of connected services. WEP Clinical has offices located at London, United Kingdom; RTP North Carolina, United States; Lisbon, Portugal; and Dublin, Ireland.

“We couldn’t be more excited to welcome TJC into our next phase of growth,” said Jaswinder khera, WEP Clinical Co-Founder and General Manager USA “There is a great cultural fit between our organizations and we share a vision for the future of WEP Clinical. TJC’s resources and experience will enable us to accelerate our long-term growth plan. ”

“With the strategic and financial support of TJC, we are confident that WEP Clinical will continue its current history of success,” said Jaswant khera, co-founder of WEP Clinical and general manager of the EU. “We believe this partnership will accelerate our organic and inorganic growth initiatives as we continue to invest significantly in our people and capabilities to serve our customers. ”

“We are honored to partner with the entire WEP clinical team and join their mission to help those in need while providing world-class assistance to clients,” said Dan Williams, partner at TJC. “We see great growth opportunities for the company and look forward to supporting the business as it grows.”

McDermott, Will and Emery LLP acted as legal counsel and Cain Brothers, a division of KeyBanc Capital Markets Inc., acted as financial advisor to WEP Clinical. Kirkland & Ellis LLP acted as legal counsel to TJC.

For any questions, please contact Kristin A. Custar, Partner and Group Head of Global Investor Capital at TJC, at (212) 572-0829.

About WEP Clinic
Founded in 2008, WEP Clinical is a specialty pharmacy services company that works with drug developers to help patients and physicians access drugs quickly when no other treatment option is available. WEP has offices located at London, United Kingdom; RTP North Carolina, United States; Lisbon, Portugal; and Dublin, Ireland and have all the licenses necessary to meet the needs of access and distribution of medicines in all regions of the world. We are passionate about helping people in need. For more information, please visit

About Jordan Company
TJC, founded in 1982, is a mid-sized private equity firm that has managed funds with initial capital commitments greater than $ 17 billion and 39 years of experience in investing and contributing to the growth of numerous companies in a wide range of sectors, including health and consumer; Industrialists; Technology, telecommunications and utilities; and Transport & Logistics. The senior investment team have been investing together for over 20 years and are supported by the Operations Management Group, which was established in 1988 to initiate and support operational improvements in portfolio companies. Based at new York, TJC also has offices in Chicago and Stamford. For more information, please visit


Kristin custar
Partner, head of the Global Investor Capital group
The Jordan Company
(212) 572-0829

SOURCE The Jordan Company, LP

Related links


About Author

Comments are closed.